Publications by authors named "Francesc Pons"

Claim this Profile
S
Serrated epithelial lesion with dysplasia as a precursor to small bowel carcinoma associated with Crohn's disease.
Míriam Gené, Anna Alguersuari, Francesc Pons, Carla Miñambres, Eva Musulén

Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.
Margarita Romeo, Francesc Pons, Pilar Barretina, Joaquim Radua

World J Surg Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of sunitinib in combination with gemcitabine and capecitabine for first-line treatment of metastatic or unresectable renal cell carcinoma.
Joaquim Bellmunt, Cristina Suarez, Enrique Gallardo, Jordi Rodon, Francesc Pons

Oncologist· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential targeted therapy after pazopanib therapy in patients with metastatic renal cell cancer: efficacy and toxicity.
Joaquim Bellmunt, Francesc Pons, Abigail Foreshew, André P Fay, Thomas Powles

Clin Genitourin Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib malate in the treatment of urothelial cancer.
Francesc Pons, Joaquim Bellmunt

Expert Opin Investig Drugs· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.
Carlos Gomez-Martin, Jose Carlos Plaza, Roberto Pazo-Cid, Antonieta Salud, Francesc Pons

J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of response to cisplatin-based neoadjuvant chemotherapy.
Joaquim Bellmunt, Francesc Pons, Anna Orsola

Curr Opin Urol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.
Margarita Romeo, Francesc Pons, Pilar Barretina, Joaquim Radua

World J Surg Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
Katherine M Krajewski, Ronan Fougeray, Joaquim Bellmunt, Francesc Pons, Fabio A B Schutz

Eur J Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variant forms of bladder cancer: basic considerations on treatment approaches.
Francesc Pons, Anna Orsola, Juan Morote, Joaquim Bellmunt

Curr Oncol Rep· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic uveal melanoma: is there a role for conventional chemotherapy? - A single center study based on 58 patients.
Francesc Pons, Maria Plana, Josep Maria Caminal, Joan Pera, Isabel Fernandes

Melanoma Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis